(Oct 27): Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc in a deal valued at US$12 billion, making ...
The sustained buying blitz brings Arnault and his family closer to owning half of the high-end brand juggernaut.
Singapore Business Review on MSN
Investors told to convert existing buildings as co-living demand rises
Investors should repurpose existing assets such as small commercial buildings and shophouses into co-living spaces to meet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback